Downregulation of ubiquitin-associated protein 2-like with a short hairpin RNA inhibits human glioma cell growth in vitro

Zhao,Bing; Zong,Gang; Xie,Yongsheng; Li,Jia; Wang,Hongliang; Bian,Erbao

doi:10.3892/ijmm.2015.2323

Downregulation of ubiquitin-associated protein 2-like with a short hairpin RNA inhibits human glioma cell growth in vitro

Authors:
- Bing Zhao
- Gang Zong
- Yongsheng Xie
- Jia Li
- Hongliang Wang
- Erbao Bian
View Affiliations

Affiliations: Department of Neurosurgery, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230601, P.R. China
Published online on: August 24, 2015 https://doi.org/10.3892/ijmm.2015.2323
Pages: 1012-1018
Copyright: © Zhao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Ubiquitin-associated protein 2-like (UBAP2L), which contains a ubiquitin-associated (UBA) domain near its N-terminus, has been indicated in the pathogenesis of several human cancers, including multiple myeloma, hepatocellular carcinoma and malignant ovarian tumors. However, the role of UBAP2L in human glioma remains unknown. In the present study, UBAP2L was widely expressed in multiple glioma cell lines. To further examine the effects of UBAP2L on glioma growth, lentivirus‑mediated short hairpin RNA (shRNA) was employed to knockdown UBAP2L expression in the glioblastoma cell lines. Depletion of UBAP2L significantly inhibited the proliferation and colony formation ability, as determined by MTT and colony formation assays. Cell cycle analysis showed that UBAP2L knockdown induced G0/G1 phase arrest in U251 and U373 cells, while S phase arrest was induced in A172 cells. These results suggest that UBAP2L has a key role in glioma cell growth, and may act as an oncogene to promote malignant glioma development.

View Figures

View References

1	Wen PY and Kesari S: Malignant gliomas in adults. N Engl J Med. 359:492–507. 2008. View Article : Google Scholar : PubMed/NCBI
2	Hanahan D and Weinberg RA: Hallmarks of cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
3	Sakamoto KM, Kim KB, Verma R, Ransick A, Stein B, Crews CM and Deshaies RJ: Development of Protacs to target cancer-promoting proteins for ubiquitination and degradation. Mol Cell Proteomics. 2:1350–1358. 2003. View Article : Google Scholar : PubMed/NCBI
4	Wei W and Lin H-K: The key role of ubiquitination and sumoylation in signaling and cancer: A research topic. Front Oncol. 2:1872012. View Article : Google Scholar : PubMed/NCBI
5	Yamaguchi H, Hsu JL and Hung MC: Regulation of ubiqui-tination-mediated protein degradation by survival kinases in cancer. Front Oncol. 2:152012. View Article : Google Scholar
6	Vlachostergios PJ, Voutsadakis IA and Papandreou CN: The ubiquitin-proteasome system in glioma cell cycle control. Cell Div. 7:182012. View Article : Google Scholar : PubMed/NCBI
7	Ciechanover A: Intracellular protein degradation: From a vague idea through the lysosome and the ubiquitin-proteasome system and onto human diseases and drug targeting. Bioorg Med Chem. 21:3400–3410. 2013. View Article : Google Scholar : PubMed/NCBI
8	Wilde IB, Brack M, Winget JM and Mayor T: Proteomic char-acterization of aggregating proteins after the inhibition of the ubiquitin proteasome system. J Proteome Res. 10:1062–1072. 2011. View Article : Google Scholar : PubMed/NCBI
9	Sawyer JR: The prognostic significance of cytogenetics and molecular profiling in multiple myeloma. Cancer Genet. 204:3–12. 2011. View Article : Google Scholar : PubMed/NCBI
10	Zhu Z-Z, Wang D, Cong W-M, Jiang H, Yu Y, Wen BJ, Dong H, Zhang X, Liu SF, Wang AZ, et al: Sex-related differences in DNA copy number alterations in hepatitis B virus-associated hepatocellular carcinoma. Asian Pac J Cancer Prev. 13:225–229. 2012. View Article : Google Scholar : PubMed/NCBI
11	Naz RK and Dhandapani L: Identification of human sperm proteins that interact with human zona pellucida3 (ZP3) using yeast two-hybrid system. J Reprod Immunol. 84:24–31. 2010. View Article : Google Scholar :
12	Madura K: The ubiquitin-associated (UBA) domain: On the path from prudence to prurience. Cell Cycle. 1:235–244. 2002. View Article : Google Scholar : PubMed/NCBI
13	Sakoda T, Kasahara N, Hamamori Y and Kedes L: A high-titer lentiviral production system mediates efficient transduction of differentiated cells including beating cardiac myocytes. J Mol Cell Cardiol. 31:2037–2047. 1999. View Article : Google Scholar : PubMed/NCBI
14	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar
15	Rahman NA, Bennink HJTC, Chrusciel M, Sharp V, Zimmerman Y, Dina R, Li X, Ellonen A, Rivero-Müller A, Dilworth S, et al: A novel treatment strategy for ovarian cancer based on immunization against zona pellucida protein (ZP) 3. FASEB J. 26:324–333. 2012. View Article : Google Scholar
16	Sudhir PR, Hsu CL, Wang MJ, Wang YT, Chen YJ, Sung TY, Hsu WL, Yang UC and Chen JY: Phosphoproteomics identifies oncogenic Ras signaling targets and their involvement in lung adenocarcinomas. PLoS One. 6:e201992011. View Article : Google Scholar : PubMed/NCBI
17	Olsen BB, Svenstrup TH and Guerra B: Downregulation of protein kinase CK2 induces autophagic cell death through modulation of the mTOR and MAPK signaling pathways in human glioblastoma cells. Int J Oncol. 41:1967–1976. 2012.PubMed/NCBI
18	Bank A, Dorazio R and Leboulch P: A phase I/II clinical trial of beta-globin gene therapy for beta-thalassemia. Ann N Y Acad Sci. 1054:308–316. 2005. View Article : Google Scholar : PubMed/NCBI
19	Fang J, Yu Z, Lian M, Ma H, Tai J, Zhang L and Han D: Knockdown of zinc finger protein, X-linked (ZFX) inhibits cell proliferation and induces apoptosis in human laryngeal squamous cell carcinoma. Mol Cell Biochem. 360:301–307. 2012. View Article : Google Scholar
20	Sherr CJ: The Pezcoller lecture: Cancer cell cycles revisited. Cancer Res. 60:3689–3695. 2000.PubMed/NCBI
21	Piva R, Cancelli I, Cavalla P, Bortolotto S, Dominguez J, Draetta GF and Schiffer D: Proteasome-dependent degradation of p27/kip1 in gliomas. J Neuropathol Exp Neurol. 58:691–696. 1999. View Article : Google Scholar : PubMed/NCBI
22	Pamarthy D, Tan M, Wu M, Chen J, Yang D, Wang S, Zhang H and Sun Y: p27 degradation by an ellipticinium series of compound via ubiquitin-proteasome pathway. Cancer Biol Ther. 6:360–366. 2007. View Article : Google Scholar : PubMed/NCBI
23	Amador V, Ge S, Santamaría PG, Guardavaccaro D and Pagano M: APC/C(Cdc20) controls the ubiquitin-mediated degradation of p21 in prometaphase. Mol Cell. 27:462–473. 2007. View Article : Google Scholar : PubMed/NCBI
24	An J, Yang DY, Xu QZ, Zhang SM, Huo YY, Shang ZF, Wang Y, Wu DC and Zhou PK: DNA-dependent protein kinase catalytic subunit modulates the stability of c-Myc oncoprotein. Mol Cancer. 7:322008. View Article : Google Scholar : PubMed/NCBI
25	Ying H and Xiao ZX: Targeting retinoblastoma protein for degradation by proteasomes. Cell Cycle. 5:506–508. 2006. View Article : Google Scholar : PubMed/NCBI
26	Ohgaki H and Kleihues P: Genetic pathways to primary and secondary glioblastoma. Am J Pathol. 170:1445–1453. 2007. View Article : Google Scholar : PubMed/NCBI